Nifedipine antihypertensive treatment effects in pre-eclampsia.
DOI:
https://doi.org/10.20344/amp.796Abstract
Literature analysis has been controversial about pre-eclampsia. It is known that not pregnant patients should be treated due cardiovascular benefits. However, the real benefits of antihypertensive treatment in pre-eclampsia were not demonstrated. Yet, there are many drugs that can be used for antihypertensive treatment in pregnancy. Calcium cannel blockers, particularly nifedipine, are used as a second line treatment. There are just a few evidences about nifedipine treatment in hypertension during pregnancy. Recently, researches were performed to evaluate the effects of nifedipine on maternal-fetal binomial, more safety, efficacy, and effectiveness were found using it. This literature review concludes that hypertension treatment only must be done in severe cases and emergency hypertensive. Therefore nifedipine can be used in antihypertensive treatment during pregnancy without serious complications.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
